The extracellular matrix (ECM) is a complex and dynamic structural network that plays a crucial role in maintaining tissue architecture and regulating cellular functions such as proliferation, migration, and differentiation. ECM dynamics involve continuous remodeling through processes of synthesis and degradation, mediated by enzymes like matrix metalloproteinases (MMPs). This balance is essential for normal physiological processes such as wound healing, tissue regeneration, and development. Dysregulation of ECM dynamics can lead to pathological conditions, including cancer, fibrosis, and chronic wounds, where altered ECM composition and stiffness can drive disease progression by influencing cell behavior. In addition to providing mechanical support, the ECM interacts with cells through integrins and other surface receptors, modulating key signaling pathways that determine cell fate and response to external stimuli. Understanding these interactions is critical for developing targeted therapies aimed at manipulating ECM dynamics in various clinical contexts. Emerging technologies, such as 3D bioprinting and microfluidic devices, are enhancing our ability to replicate and study ECM behavior in vitro, offering new insights into disease mechanisms and potential therapeutic applications. Research into ECM dynamics is advancing the fields of tissue engineering, regenerative medicine, and cancer therapy, with the potential to improve clinical outcomes by targeting ECM-mediated pathways.